Gary Perry is a seasoned professional in regulatory affairs, currently serving as the Director of Global Regulatory Affairs, Development Strategy at Alexion Pharmaceuticals, Inc. since April 2024. With a longstanding career at Pfizer Pharmaceuticals starting in January 1993, Gary has held various roles including Director of Regulatory Affairs, where responsibilities included serving as the Global Regulatory Lead for a Phase 3b Development Program for Rheumatoid Arthritis. Previous positions at Pfizer involved supporting regulatory projects across numerous disease areas. Earlier experience includes roles as QA Manager at Springborn Laboratories and as an Analytical Chemist at Stauffer Chemical Company. Gary holds a Bachelor of Science degree in Chemistry from Assumption University.
This person is not in any teams
This person is not in any offices